Tirzepatide 5mg
$79.99
Description
Tirzepatide 5 mg
Tirzepatide is a once-weekly injectable medication that activates both GIP and GLP-1 receptors. FDA-approved tirzepatide products include Zepbound for chronic weight management and Mounjaro for type 2 diabetes.
5 mg is an established maintenance dose. For Zepbound, the labeled schedule starts at 2.5 mg once weekly, increases to 5 mg after 4 weeks, and may be increased by 2.5 mg increments if appropriate.
Potential benefits
- Helps reduce appetite and food intake
- Promotes weight loss when used with diet and physical activity
- Improves blood-glucose control in people with type 2 diabetes
- Can improve certain metabolic risk factors
